Cambridge, Massachusetts, United States
Contact Info
15K followers
500+ connections
Cambridge, Massachusetts, United States
Contact Info
15K followers
500+ connections
About
I work in the best industry in the world. An industry that tackles the most serious…
Articles by Bill
-
Our Role in Addressing the Realities of Metastatic Breast Cancer
Our Role in Addressing the Realities of Metastatic Breast Cancer
By Bill Sibold
-
A Rare Moment: Recognizing Our Commitment to the Global Rare Disease Community
A Rare Moment: Recognizing Our Commitment to the Global Rare Disease Community
By Bill Sibold
-
How We’re Keeping Patients at the Center of Our Cancer Efforts
How We’re Keeping Patients at the Center of Our Cancer Efforts
By Bill Sibold
Activity
-
We’re pleased to announce the appointment of Vanessa Wolfeler as the new CEO of SERB Pharmaceuticals. Vanessa is an accomplished leader with broad…
We’re pleased to announce the appointment of Vanessa Wolfeler as the new CEO of SERB Pharmaceuticals. Vanessa is an accomplished leader with broad…
Liked by Bill Sibold
-
We’re excited to welcome Naimish Patel, M.D., who is joining CRISPR Therapeutics as Chief Medical Officer. Dr. Patel brings extensive drug…
We’re excited to welcome Naimish Patel, M.D., who is joining CRISPR Therapeutics as Chief Medical Officer. Dr. Patel brings extensive drug…
Liked by Bill Sibold
Experience & Education
More activity by Bill
-
The Madrigal team continues to grow as we pursue our goal of delivering the first foundational therapy for patients with NASH with significant…
The Madrigal team continues to grow as we pursue our goal of delivering the first foundational therapy for patients with NASH with significant…
Shared by Bill Sibold
-
Great to have Ron Filippo joining our team as Chief Information Officer. Ron’s skillset and depth of digital experience will be a tremendous asset…
Great to have Ron Filippo joining our team as Chief Information Officer. Ron’s skillset and depth of digital experience will be a tremendous asset…
Shared by Bill Sibold
-
Big thanks to Terri and our partners in the NASH patient community for inspiring this campaign and bringing the "Olivia" character to life!
Big thanks to Terri and our partners in the NASH patient community for inspiring this campaign and bringing the "Olivia" character to life!
Shared by Bill Sibold
-
Carole Huntsman’s leadership skills and experience are a perfect fit for Madrigal as we prepare for a first-to-market launch of resmetirom in…
Carole Huntsman’s leadership skills and experience are a perfect fit for Madrigal as we prepare for a first-to-market launch of resmetirom in…
Shared by Bill Sibold
-
Today is my last day as CEO of ALK. Almost seven years ago, I took over the baton, and tomorrow I will hand it over to ALK’s new CEO, Peter Halling.…
Today is my last day as CEO of ALK. Almost seven years ago, I took over the baton, and tomorrow I will hand it over to ALK’s new CEO, Peter Halling.…
Liked by Bill Sibold
-
Yesterday - 10/19 - was International #NiemannPickAwareness Day. I spent the day thinking about what to write, stuck on how to capture what this day…
Yesterday - 10/19 - was International #NiemannPickAwareness Day. I spent the day thinking about what to write, stuck on how to capture what this day…
Liked by Bill Sibold
-
Great to see the Phase 3 MAESTRO-NAFLD-1 results published in Nature Medicine. Madrigal has established the largest and most advanced clinical…
Great to see the Phase 3 MAESTRO-NAFLD-1 results published in Nature Medicine. Madrigal has established the largest and most advanced clinical…
Shared by Bill Sibold
-
Last week, our annual R&D Global Scientific Symposium brought us together to celebrate our incredible science, progress and people. It was an…
Last week, our annual R&D Global Scientific Symposium brought us together to celebrate our incredible science, progress and people. It was an…
Liked by Bill Sibold
-
This Financing represents a major step forward for Madrigal as we prepare for a potential first-to-market launch in NASH. Madrigal is a leader in…
This Financing represents a major step forward for Madrigal as we prepare for a potential first-to-market launch in NASH. Madrigal is a leader in…
Shared by Bill Sibold
-
Press Release: Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering https://lnkd.in/d2RRcbHm
Press Release: Madrigal Pharmaceuticals Announces Pricing of $500 Million Public Offering https://lnkd.in/d2RRcbHm
Liked by Bill Sibold
-
It is an honor to be succeeding Dr. Paul Friedman as CEO of Madrigal and I’m thrilled to be joining an amazing team that is dedicated to improving…
It is an honor to be succeeding Dr. Paul Friedman as CEO of Madrigal and I’m thrilled to be joining an amazing team that is dedicated to improving…
Shared by Bill Sibold
-
I’m happy to share that I’m starting a new position as Chief Executive Officer at Madrigal Pharmaceuticals
I’m happy to share that I’m starting a new position as Chief Executive Officer at Madrigal Pharmaceuticals
Posted by Bill Sibold
-
It isn’t easy to say that today is my last day at Sanofi. What is easy to say is that over the last 12 years, I have worked alongside incredible…
It isn’t easy to say that today is my last day at Sanofi. What is easy to say is that over the last 12 years, I have worked alongside incredible…
Shared by Bill Sibold
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More